Related Experiment Video
Updated: Mar 10, 2026

Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
Published on: April 13, 2022
Hydrophobically modified chitosan gauze: a novel topical hemostat
Apurva Chaturvedi1, Matthew B Dowling2, John P Gustin3
1Program in Trauma, R Adams Cowley Shock Trauma Center, University of Maryland, School of Medicine, Baltimore, Maryland.
Hydrophobically modified chitosan (hm-C) gauze demonstrated superior hemostasis compared to Combat Gauze (CG) and ChitoGauze (ChG) in a lethal hemorrhage model, showing improved survival and reduced blood loss.
Area of Science:
- Biomaterials Science
- Trauma Medicine
- Surgical Hemostasis
Background:
- Combat Gauze (CG) is the standard hemostatic agent for severe military hemorrhage.
- Hydrophobically modified chitosan (hm-C) exhibits enhanced hemostatic properties over native chitosan.
- This study evaluates hm-C gauze against established hemostatic dressings.
Purpose of the Study:
- To compare the efficacy of hm-C gauze against Combat Gauze (CG) and ChitoGauze (ChG).
- To assess hemostatic performance in a lethal in vivo hemorrhage model.
- To evaluate survival rates, dressing usage, and blood loss.
Main Methods:
- A randomized lethal hemorrhage model using Yorkshire swine.
- Comparison of hm-C gauze, ChitoGauze (ChG), and Combat Gauze (CG).
- Femoral artery puncture model with 30 seconds of free bleeding followed by dressing application and 3-minute compression.
Main Results:
- hm-C gauze achieved 100% survival, outperforming CG (75%) and ChG (75%).
- Total blood loss was significantly lower with hm-C gauze (4.7 mL/kg) compared to CG (13.4 mL/kg) and ChG (12.1 mL/kg).
- Hemostasis duration was longer with hm-C gauze (3 hours) versus CG (2.25 hours).
Conclusions:
- hm-C gauze shows superior performance in a lethal hemorrhage model compared to CG and ChG.
- While trends favored hm-C gauze, statistical significance was not reached for key endpoints.
- Future studies will utilize hypothermic, coagulopathic models to differentiate outcomes in smaller treatment groups.
More Related Videos
08:59A Freeze-Thawing Method to Prepare Chitosan-Polyvinyl alcohol Hydrogels Without Crosslinking Agents and Diflunisal Release Studies
Published on: January 14, 2020
12:22Synthesis of Thermogelling PolyN-isopropylacrylamide-graft-chondroitin Sulfate Composites with Alginate Microparticles for Tissue Engineering
Published on: October 26, 2016